Thinking of joining a study?

Register your interest

NCT06156059 | NOT YET RECRUITING | Septic Shock


Oral Bedtime Melatonin in Critically Ill Patients
Sponsor:

San Carlos Hospital, Madrid

Information provided by (Responsible Party):

Miguel Sanchez Garcia

Brief Summary:

Oxidative stress is one of the main mechanisms causing harm in severe infection with septic shock, ischemia-reperfusion injury in resuscitated cardiac arrest and ischemic and hemorrhagic stroke. Melatonin is a potent scavenger of the mediators of oxidative stress, oxygen and nitrogen-reactive species, which directly injure cell structures like walls and DNA and thus cause organ dysfunction. In a previous study we have observed that high-dose oral bedtime melatonin (OBM) is associated with improved organ function in severe Covid-19 patients

Condition or disease

Septic Shock

Stroke Hemorrhagic

Strokes Thrombotic

Cardiac Arrest

Intervention/treatment

Oral Bedtime Melatonin

Placebo suspension or capsule

Phase

PHASE4

Detailed Description:

This is a double-blind randomized, adaptive trial in the 4 indications mentioned above giving 100 mg of OBM or placebo. Interim analyses with pre-specified stopping rules will be performed in each sub-study for specific outcome variables collected at scheduled timelines. Comparative organ dysfunction score (Sequential Organ Failure Evaluation-SOFA) will be done at baseline, 7, 14, and 30 days and mortality evaluated at 30 and 90 days. For the 3 study groups enrolling stroke and resuscitated cardiac arrest patients, the modified Rankin score and the CVC (Glasgow) at 30 and 90 days will be compared.

Study Type : INTERVENTIONAL
Estimated Enrollment : 160 participants
Masking : QUADRUPLE
Masking Description : Indistinguishable oral suspension or capsule
Primary Purpose : TREATMENT
Official Title : Oral Bedtime Melatonin in Critically Ill Patients
Actual Study Start Date : 2025-02-01
Estimated Primary Completion Date : 2026-02-01
Estimated Study Completion Date : 2026-04-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * ICU stay \>5 days
Exclusion Criteria
  • * ominous prognosis

Oral Bedtime Melatonin in Critically Ill Patients

Location Details

NCT06156059


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


No Location Found

Loading...